These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 33137375

  • 1. Novel deoxyvasicinone and tetrahydro-beta-carboline hybrids as inhibitors of acetylcholinesterase and amyloid beta aggregation.
    Du H, Jiang X, Ma M, Xu H, Liu S, Ma F.
    Bioorg Med Chem Lett; 2020 Dec 15; 30(24):127659. PubMed ID: 33137375
    [Abstract] [Full Text] [Related]

  • 2. Novel hydroxybenzylamine-deoxyvasicinone hybrids as anticholinesterase therapeutics for Alzheimer's disease.
    Bowroju SK, Penthala NR, Lakkaniga NR, Balasubramaniam M, Ayyadevara S, Shmookler Reis RJ, Crooks PA.
    Bioorg Med Chem; 2021 Sep 01; 45():116311. PubMed ID: 34304133
    [Abstract] [Full Text] [Related]

  • 3. New coumarin-benzotriazole based hybrid molecules as inhibitors of acetylcholinesterase and amyloid aggregation.
    Singh A, Sharma S, Arora S, Attri S, Kaur P, Kaur Gulati H, Bhagat K, Kumar N, Singh H, Vir Singh J, Mohinder Singh Bedi P.
    Bioorg Med Chem Lett; 2020 Oct 15; 30(20):127477. PubMed ID: 32781220
    [Abstract] [Full Text] [Related]

  • 4. Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease.
    Lan JS, Xie SS, Li SY, Pan LF, Wang XB, Kong LY.
    Bioorg Med Chem; 2014 Nov 01; 22(21):6089-104. PubMed ID: 25282654
    [Abstract] [Full Text] [Related]

  • 5. New phosphazine and phosphazide derivatives as multifunctional ligands targeting acetylcholinesterase and β-Amyloid aggregation for treatment of Alzheimer's disease.
    El-Sayed NF, El-Hussieny M, Ewies EF, Fouad MA, Boulos LS.
    Bioorg Chem; 2020 Jan 01; 95():103499. PubMed ID: 31838287
    [Abstract] [Full Text] [Related]

  • 6. Design, synthesis and evaluation of novel bivalent β-carboline derivatives as multifunctional agents for the treatment of Alzheimer's disease.
    Zhao Y, Ye F, Xu J, Liao Q, Chen L, Zhang W, Sun H, Liu W, Feng F, Qu W.
    Bioorg Med Chem; 2018 Jul 30; 26(13):3812-3824. PubMed ID: 29960728
    [Abstract] [Full Text] [Related]

  • 7. Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors.
    Lan JS, Zhang T, Liu Y, Yang J, Xie SS, Liu J, Miao ZY, Ding Y.
    Eur J Med Chem; 2017 Jun 16; 133():184-196. PubMed ID: 28388521
    [Abstract] [Full Text] [Related]

  • 8. Novel chromanone-dithiocarbamate hybrids as multifunctional AChE inhibitors with β-amyloid anti-aggregation properties for the treatment of Alzheimer's disease.
    Jiang N, Ding J, Liu J, Sun X, Zhang Z, Mo Z, Li X, Yin H, Tang W, Xie SS.
    Bioorg Chem; 2019 Aug 16; 89():103027. PubMed ID: 31176237
    [Abstract] [Full Text] [Related]

  • 9. Biological evaluation of synthetic α,β-unsaturated carbonyl based cyclohexanone derivatives as neuroprotective novel inhibitors of acetylcholinesterase, butyrylcholinesterase and amyloid-β aggregation.
    Zha GF, Zhang CP, Qin HL, Jantan I, Sher M, Amjad MW, Hussain MA, Hussain Z, Bukhari SN.
    Bioorg Med Chem; 2016 May 15; 24(10):2352-9. PubMed ID: 27083471
    [Abstract] [Full Text] [Related]

  • 10. Novel deoxyvasicinone derivatives as potent multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation.
    Ma F, Du H.
    Eur J Med Chem; 2017 Nov 10; 140():118-127. PubMed ID: 28923380
    [Abstract] [Full Text] [Related]

  • 11. Synthesis, biological evaluation and molecular modeling of benzofuran piperidine derivatives as Aβ antiaggregant.
    Chowdhury SR, Gu J, Hu Y, Wang J, Lei S, Tavallaie MS, Lam C, Lu D, Jiang F, Fu L.
    Eur J Med Chem; 2021 Oct 15; 222():113541. PubMed ID: 34116326
    [Abstract] [Full Text] [Related]

  • 12. Pterostilbene-O-acetamidoalkylbenzylamines derivatives as novel dual inhibitors of cholinesterase with anti-β-amyloid aggregation and antioxidant properties for the treatment of Alzheimer's disease.
    Li Y, Qiang X, Li Y, Yang X, Luo L, Xiao G, Cao Z, Tan Z, Deng Y.
    Bioorg Med Chem Lett; 2016 Apr 15; 26(8):2035-9. PubMed ID: 26947607
    [Abstract] [Full Text] [Related]

  • 13. Design, synthesis and biological evaluation of new coumarin-dithiocarbamate hybrids as multifunctional agents for the treatment of Alzheimer's disease.
    Jiang N, Huang Q, Liu J, Liang N, Li Q, Li Q, Xie SS.
    Eur J Med Chem; 2018 Feb 25; 146():287-298. PubMed ID: 29407958
    [Abstract] [Full Text] [Related]

  • 14. Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives.
    Riazimontazer E, Sadeghpour H, Nadri H, Sakhteman A, Tüylü Küçükkılınç T, Miri R, Edraki N.
    Bioorg Chem; 2019 Aug 25; 89():103006. PubMed ID: 31158577
    [Abstract] [Full Text] [Related]

  • 15. Design, synthesis and biological evaluation of novel deoxyvasicinone-indole as multi-target agents for Alzheimer's disease.
    Nerella A, Jeripothula M.
    Bioorg Med Chem Lett; 2021 Oct 01; 49():128212. PubMed ID: 34153471
    [Abstract] [Full Text] [Related]

  • 16. Novel salicylamide derivatives as potent multifunctional agents for the treatment of Alzheimer's disease: Design, synthesis and biological evaluation.
    Song Q, Li Y, Cao Z, Qiang X, Tan Z, Deng Y.
    Bioorg Chem; 2019 Mar 01; 84():137-149. PubMed ID: 30500523
    [Abstract] [Full Text] [Related]

  • 17. Semi-synthesis and biological evaluation of flavone hybrids as multifunctional agents for the potential treatment of Alzheimer's disease.
    Shi S, Wang H, Wang J, Wang Y, Xue X, Hou Z, Yao GD, Huang XX, Zhao H, Liu Q, Song SJ.
    Bioorg Chem; 2020 Jul 01; 100():103917. PubMed ID: 32442817
    [Abstract] [Full Text] [Related]

  • 18. Novel 3-benzylidene/benzylphthalide Mannich base derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
    Cao Z, Song Q, Yu G, Liu Z, Cong S, Tan Z, Deng Y.
    Bioorg Med Chem; 2021 Apr 01; 35():116074. PubMed ID: 33640707
    [Abstract] [Full Text] [Related]

  • 19. Design, synthesis, and in vitro evaluation of 4-aminoalkyl-1(2H)-phthalazinones as potential multifunctional anti-Alzheimer's disease agents.
    Ye C, Xu R, Cao Z, Song Q, Yu G, Shi Y, Liu Z, Liu X, Deng Y.
    Bioorg Chem; 2021 Jun 01; 111():104895. PubMed ID: 33887586
    [Abstract] [Full Text] [Related]

  • 20. Development of cyanopyridine-triazine hybrids as lead multitarget anti-Alzheimer agents.
    Maqbool M, Manral A, Jameel E, Kumar J, Saini V, Shandilya A, Tiwari M, Hoda N, Jayaram B.
    Bioorg Med Chem; 2016 Jun 15; 24(12):2777-88. PubMed ID: 27157006
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.